The interaction between bacteria and fibronectin is believed to play an important role in the pathogenicity of clinically important Gram-positive cocci. In the present study, we identified a gene encoding a predicted fibronectin-binding protein of Enterococcus faecium (fnm), a homologue of Streptococcus pneumoniae pavA, in the genomes of E. faecium strain TX82 and all other sequenced E. faecium isolates. Full-length recombinant Fnm from strain TX82 bound to immobilized fibronectin in a concentration-dependent manner and also appeared to bind collagen type V and laminin, but not other proteins, such as transferrin, heparin, bovine serum albumin, mucin, or collagen IV. We demonstrated that the N-terminal fragment of Fnm is required for full fibronectin binding, since truncation of this region caused a 2.4-fold decrease (P < 0.05) in the adhesion of E. faecium TX82 to fibronectin. Deletion of fnm resulted in a significant reduction (P < 0.001) in the ability of the mutant, TX6128, to bind fibronectin relative to that of the wild-type strain; in situ reconstitution of fnm in the deletion mutant strain restored adherence. In addition, the ⌬fnm mutant was highly attenuated relative to TX82 (P < 0.0001) in a mixed-inoculum rat endocarditis model. Taken together, these results demonstrate that Fnm affects the adherence of E. faecium to fibronectin and is important in the pathogenesis of experimental endocarditis.
Bacterial adherence to host tissues and extracellular matrix (ECM) proteins is a critical step in the process of infection, since it establishes the initial contact with the host. These interactions can facilitate translocation across the mucosal barrier and internalization into subcellular compartments, eventually leading to bacterial spread within eukaryotic cells (1). Particularly in Gram-positive pathogens, surface-exposed adherence molecules, such as MSCRAMMs (microbial surface components recognizing adhesive matrix molecules), are key players in host-microbe interactions (2). Host ligands include ECM components, e.g., fibronectin, collagen, and laminin, as well as molecules that are also present in blood, including fibrinogen and vitronectin (2).Generally reported as a well-adapted commensal of the gastrointestinal tracts of humans and animals, Enterococcus faecium has emerged over the past 3 decades as a leading cause of hospitalassociated diseases, including urinary tract infections (UTIs), bacteremia, intra-abdominal infections, and endocarditis (3-5). The rising incidence of multiantibiotic-resistant nosocomial infections caused by E. faecium has led to the inclusion of these organisms in the list of "no ESKAPE" (E. faecium, Staphylococcus aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacteriaceae) pathogens that pose a challenge to clinicians and threaten patient safety (6). In the United States, approximately 80% of health careassociated E. faecium strains are vancomycin-resistant enterococci (VRE), and more than 90% are ampicillin resistant (5). The frequent lack of an antibiotic regime...